Cargando…
AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine
Heart failure (HF) is a complex clinical syndrome that represents the advanced stage of cardiovascular disease, characterized by systolic and diastolic dysfunction of the heart. Despite continuous updates in HF treatment drugs, the morbidity and mortality rates remain high, necessitating ongoing exp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676094/ https://www.ncbi.nlm.nih.gov/pubmed/38026240 http://dx.doi.org/10.2147/JIR.S441597 |
_version_ | 1785149906784092160 |
---|---|
author | Liu, Changxing Guo, Xinyi Zhou, Yabin Wang, He |
author_facet | Liu, Changxing Guo, Xinyi Zhou, Yabin Wang, He |
author_sort | Liu, Changxing |
collection | PubMed |
description | Heart failure (HF) is a complex clinical syndrome that represents the advanced stage of cardiovascular disease, characterized by systolic and diastolic dysfunction of the heart. Despite continuous updates in HF treatment drugs, the morbidity and mortality rates remain high, necessitating ongoing exploration for new therapeutic targets. Adenosine monophosphate-activated protein kinase (AMPK) is the serine/threonine protein kinase which responds to adenosine monophosphate (AMP) levels.Activation of AMPK shifts cellular metabolic patterns from synthesis to catabolism, enhancing energy metabolism in pathological conditions such as inflammation, ischemia, obesity, and aging. Numerous studies have identified AMPK as a vital target for HF treatment, with herbal monomers/extracts and compounds affecting key signaling factors including rapamycin targeting protein (mTOR), silencing regulator protein 1 (SIRT1), nuclear transcription factor E2-related factor 2 (Nrf2), and nuclear transcription factor-κB (NF-κB) through regulation of the AMPK signaling pathway.This modulation can achieve the effects of improving metabolism, autophagy, reducing oxidative stress and inflammatory response in the treatment of heart failure, with the advantages of multi-targeting, comprehensive action and low toxicity.The modulation of the AMPK pathway by Traditional Chinese Medicine (TCM) has emerged as a crucial research direction for the prevention and treatment of HF, but a systematic summary and generalization in this field is lacking. This article provides an overview of the composition, regulation, and mechanism of the AMPK signaling pathway’s influence on HF, as well as a summary of current research on the regulation of the AMPK pathway by TCM for HF prevention and treatment. The aim is to serve as a reference for the diagnosis and treatment of HF using TCM and the development of new drugs. |
format | Online Article Text |
id | pubmed-10676094 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-106760942023-11-21 AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine Liu, Changxing Guo, Xinyi Zhou, Yabin Wang, He J Inflamm Res Review Heart failure (HF) is a complex clinical syndrome that represents the advanced stage of cardiovascular disease, characterized by systolic and diastolic dysfunction of the heart. Despite continuous updates in HF treatment drugs, the morbidity and mortality rates remain high, necessitating ongoing exploration for new therapeutic targets. Adenosine monophosphate-activated protein kinase (AMPK) is the serine/threonine protein kinase which responds to adenosine monophosphate (AMP) levels.Activation of AMPK shifts cellular metabolic patterns from synthesis to catabolism, enhancing energy metabolism in pathological conditions such as inflammation, ischemia, obesity, and aging. Numerous studies have identified AMPK as a vital target for HF treatment, with herbal monomers/extracts and compounds affecting key signaling factors including rapamycin targeting protein (mTOR), silencing regulator protein 1 (SIRT1), nuclear transcription factor E2-related factor 2 (Nrf2), and nuclear transcription factor-κB (NF-κB) through regulation of the AMPK signaling pathway.This modulation can achieve the effects of improving metabolism, autophagy, reducing oxidative stress and inflammatory response in the treatment of heart failure, with the advantages of multi-targeting, comprehensive action and low toxicity.The modulation of the AMPK pathway by Traditional Chinese Medicine (TCM) has emerged as a crucial research direction for the prevention and treatment of HF, but a systematic summary and generalization in this field is lacking. This article provides an overview of the composition, regulation, and mechanism of the AMPK signaling pathway’s influence on HF, as well as a summary of current research on the regulation of the AMPK pathway by TCM for HF prevention and treatment. The aim is to serve as a reference for the diagnosis and treatment of HF using TCM and the development of new drugs. Dove 2023-11-21 /pmc/articles/PMC10676094/ /pubmed/38026240 http://dx.doi.org/10.2147/JIR.S441597 Text en © 2023 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Liu, Changxing Guo, Xinyi Zhou, Yabin Wang, He AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title | AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title_full | AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title_fullStr | AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title_full_unstemmed | AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title_short | AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine |
title_sort | ampk signalling pathway: a potential strategy for the treatment of heart failure with chinese medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676094/ https://www.ncbi.nlm.nih.gov/pubmed/38026240 http://dx.doi.org/10.2147/JIR.S441597 |
work_keys_str_mv | AT liuchangxing ampksignallingpathwayapotentialstrategyforthetreatmentofheartfailurewithchinesemedicine AT guoxinyi ampksignallingpathwayapotentialstrategyforthetreatmentofheartfailurewithchinesemedicine AT zhouyabin ampksignallingpathwayapotentialstrategyforthetreatmentofheartfailurewithchinesemedicine AT wanghe ampksignallingpathwayapotentialstrategyforthetreatmentofheartfailurewithchinesemedicine |